Ozer E, Keskin A, Berrak Y, Cankara F, Can F, Gursoy-Ozdemir Y
Discov Ment Health. 2025; 5(1):18.
PMID: 39987419
PMC: 11846830.
DOI: 10.1007/s44192-025-00128-2.
Lee J, Hyun D
Antioxidants (Basel). 2023; 12(4).
PMID: 37107292
PMC: 10135822.
DOI: 10.3390/antiox12040918.
Sivagurunathan N, Gnanasekaran P, Calivarathan L
Degener Neurol Neuromuscul Dis. 2023; 13:1-13.
PMID: 36726995
PMC: 9885882.
DOI: 10.2147/DNND.S361526.
Yang L, Cheng Y, Sun Y, Xuan Y, Niu J, Guan J
Front Aging Neurosci. 2022; 14:792778.
PMID: 35370619
PMC: 8965454.
DOI: 10.3389/fnagi.2022.792778.
Shamsi A, Shahwan M, Khan M, Husain F, Alhumaydhi F, Aljohani A
ACS Omega. 2021; 6(11):7922-7930.
PMID: 33778303
PMC: 7992174.
DOI: 10.1021/acsomega.1c00527.
Systematic Surveys of Iron Homeostasis Mechanisms Reveal Ferritin Superfamily and Nucleotide Surveillance Regulation to be Modified by PINK1 Absence.
Key J, Sen N, Arsovic A, Kramer S, Hulse R, Khan N
Cells. 2020; 9(10).
PMID: 33023155
PMC: 7650593.
DOI: 10.3390/cells9102229.
Overdosing on iron: Elevated iron and degenerative brain disorders.
DMello S, Kindy M
Exp Biol Med (Maywood). 2020; 245(16):1444-1473.
PMID: 32878460
PMC: 7553095.
DOI: 10.1177/1535370220953065.
Iron, Ferritin, Hereditary Ferritinopathy, and Neurodegeneration.
Muhoberac B, Vidal R
Front Neurosci. 2020; 13:1195.
PMID: 31920471
PMC: 6917665.
DOI: 10.3389/fnins.2019.01195.
Meta-analysis of brain iron levels of Parkinson's disease patients determined by postmortem and MRI measurements.
Wang J, Zhuang Q, Zhu L, Zhu H, Li T, Li R
Sci Rep. 2016; 6:36669.
PMID: 27827408
PMC: 5101491.
DOI: 10.1038/srep36669.
Assessing of plasma levels of iron, zinc and copper in Iranian Parkinson's disease.
Meamar R, Nikyar H, Dehghani L, Basiri K, Aghaye Ghazvini M
Adv Biomed Res. 2016; 5:31.
PMID: 27099844
PMC: 4815529.
DOI: 10.4103/2277-9175.178788.
Alterations in the basal ganglia in patients with brain tumours may be due to excessive iron deposition.
Herynek V, Wagnerova D, Malucelli A, Vymazal J, Sames M, Hajek M
Oncol Lett. 2014; 9(1):43-46.
PMID: 25435931
PMC: 4246608.
DOI: 10.3892/ol.2014.2638.
Multifunctional D2/D3 agonist D-520 with high in vivo efficacy: modulator of toxicity of alpha-synuclein aggregates.
Modi G, Voshavar C, Gogoi S, Shah M, Antonio T, Reith M
ACS Chem Neurosci. 2014; 5(8):700-17.
PMID: 24960209
PMC: 4140597.
DOI: 10.1021/cn500084x.
A low-molecular-weight ferroxidase is increased in the CSF of sCJD cases: CSF ferroxidase and transferrin as diagnostic biomarkers for sCJD.
Haldar S, Beveridge A, Wong J, Singh A, Galimberti D, Borroni B
Antioxid Redox Signal. 2013; 19(14):1662-75.
PMID: 23379482
PMC: 3809602.
DOI: 10.1089/ars.2012.5032.
The anticholinesterase phenserine and its enantiomer posiphen as 5'untranslated-region-directed translation blockers of the Parkinson's alpha synuclein expression.
Mikkilineni S, Cantuti-Castelvetri I, Cahill C, Balliedier A, Greig N, Rogers J
Parkinsons Dis. 2012; 2012:142372.
PMID: 22693681
PMC: 3368596.
DOI: 10.1155/2012/142372.
Dopamine D₂/D₃ agonists with potent iron chelation, antioxidant and neuroprotective properties: potential implication in symptomatic and neuroprotective treatment of Parkinson's disease.
Gogoi S, Antonio T, Rajagopalan S, Reith M, Andersen J, Dutta A
ChemMedChem. 2011; 6(6):991-5.
PMID: 21567969
PMC: 3492952.
DOI: 10.1002/cmdc.201100140.
Alpha-synuclein is a cellular ferrireductase.
Davies P, Moualla D, Brown D
PLoS One. 2011; 6(1):e15814.
PMID: 21249223
PMC: 3018422.
DOI: 10.1371/journal.pone.0015814.
Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples.
Kell D
Arch Toxicol. 2010; 84(11):825-89.
PMID: 20967426
PMC: 2988997.
DOI: 10.1007/s00204-010-0577-x.
Iron overload in diabetic retinopathy: a cause or a consequence of impaired mechanisms?.
Ciudin A, Hernandez C, Simo R
Exp Diabetes Res. 2010; 2010.
PMID: 20827392
PMC: 2935195.
DOI: 10.1155/2010/714108.
Late-life hemoglobin and the incidence of Parkinson's disease.
Abbott R, Ross G, Tanner C, Andersen J, Masaki K, Rodriguez B
Neurobiol Aging. 2010; 33(5):914-20.
PMID: 20709430
PMC: 3006667.
DOI: 10.1016/j.neurobiolaging.2010.06.023.
Oxidative stress and NAD+ in ischemic brain injury: current advances and future perspectives.
Ying W, Xiong Z
Curr Med Chem. 2010; 17(20):2152-8.
PMID: 20423305
PMC: 3395209.
DOI: 10.2174/092986710791299911.